{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:20:06Z","timestamp":1787786406282,"version":"build-2784847793"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":71,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"DOI":"10.1186\/s12905-026-04611-y","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:06:22Z","timestamp":1781715982000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease characteristics, treatment, and overall survival outcomes of patients with locally advanced cervical cancer referred for radiation therapy in Johannesburg, South Africa: a 2-year retrospective study"],"prefix":"10.1186","volume":"26","author":[{"given":"Oluwatosin A.","family":"Ayeni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mmereki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himal","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Okechinyere","family":"Achilonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Kassick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydnie","family":"Swanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong Carl","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Joffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mpho","family":"Ratshikana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Rendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surbhi","family":"Grover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duvern","family":"Ramiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"3","key":"4611_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"3","key":"4611_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"key":"4611_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13012-018-0718-9","volume":"13","author":"LG Johnson","year":"2018","unstructured":"Johnson LG, Armstrong A, Joyce CM, Teitelman AM, Buttenheim AM. Implementation strategies to improve cervical cancer prevention in sub-Saharan Africa: a systematic review. Implement Sci. 2018;13:1\u201318.","journal-title":"Implement Sci"},{"issue":"1","key":"4611_CR4","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41416-020-0831-9","volume":"123","author":"E Jedy-Agba","year":"2020","unstructured":"Jedy-Agba E, Joko WY, Liu B, Buziba NG, Borok M, Korir A, Masamba L, Manraj SS, Finesse A, Wabinga H, et al. Trends in cervical cancer incidence in sub-Saharan Africa. Br J Cancer. 2020;123(1):148\u201354.","journal-title":"Br J Cancer"},{"issue":"3","key":"4611_CR5","doi-asserted-by":"publisher","first-page":"e431272","DOI":"10.1200\/EDBK_431272","volume":"44","author":"ME Martinez","year":"2024","unstructured":"Martinez ME, Schmeler KM, Lajous M, Newman LA. Cancer screening in low-and middle-income countries. Am Soc Clin Oncol Educational Book. 2024;44(3):e431272.","journal-title":"Am Soc Clin Oncol Educational Book"},{"issue":"2","key":"4611_CR6","doi-asserted-by":"publisher","first-page":"e161","DOI":"10.1016\/S2214-109X(20)30459-9","volume":"9","author":"D Stelzle","year":"2021","unstructured":"Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, McAllister DA, Gottlieb SL, Klug SJ, Winkler AS. Estimates of the global burden of cervical cancer associated with HIV. lancet global health. 2021;9(2):e161\u20139.","journal-title":"lancet global health"},{"issue":"1","key":"4611_CR7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ijrobp.2018.01.067","volume":"101","author":"S Grover","year":"2018","unstructured":"Grover S, Bvochora-Nsingo M, Yeager A, Chiyapo S, Bhatia R, MacDuffie E, Puri P, Balang D, Ratcliffe S, Narasimhamurthy M, et al. Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. Int J Radiat Oncol Biol Phys. 2018;101(1):201\u201310.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4611_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/ijc.34707","volume":"154","author":"NV Fern\u00e1ndez Villalobos","year":"2024","unstructured":"Fern\u00e1ndez Villalobos NV, Ruffieux Y, Haas AD, Chinogurei C, Cornell M, Taghavi K, Egger M, Folb N, Maartens G, Rohner E. Cervical precancer and cancer incidence among insured women with and without HIV in South Africa. Int J Cancer. 2024;154(2):273\u201383.","journal-title":"Int J Cancer"},{"key":"4611_CR9","doi-asserted-by":"publisher","unstructured":"Mohuba EM, Mothiba TM, Muthelo L. Initial Clinical Presentation of Cervical Cancer Patients at Pietersburg Hospital, South Africa (2012-2014): A Retrospective Descriptive Study. Open Public Health J. 2019;12(1). https:\/\/doi.org\/10.2174\/1874944501912010238.","DOI":"10.2174\/1874944501912010238"},{"issue":"1","key":"4611_CR10","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.ijgc.2024.100008","volume":"35","author":"C Anakwenze","year":"2025","unstructured":"Anakwenze C, Kalra A, Lumley C, Chinniah G, Munsell M, Rajan T, Moorkanat G, Mehta P, Ewongwo A, Valle L. Cervical cancer stage distribution and survival outcomes in Africa: a systematic review and meta-analysis. Int J Gynecol Cancer. 2025;35(1):100008.","journal-title":"Int J Gynecol Cancer"},{"issue":"3","key":"4611_CR11","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull R, Mbele M, Makhafola T, Hicks C, Wang SM, Reis RM, Mehrotra R, Mkhize\u2013Kwitshana Z, Kibiki G, Bates DO. Cervical cancer in low and middle\u2013income countries. Oncol Lett. 2020;20(3):2058\u201374.","journal-title":"Oncol Lett"},{"issue":"11","key":"4611_CR12","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/ijc.33120","volume":"147","author":"M Sengayi-Muchengeti","year":"2020","unstructured":"Sengayi-Muchengeti M, Joko-Fru WY, Miranda-Filho A, Egue M, Akele-Akpo MT, N\u2019da G, Mathewos A, Buziba N, Korir A, Manraj S, et al. Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. Int J Cancer. 2020;147(11):3037\u201348.","journal-title":"Int J Cancer"},{"key":"4611_CR13","doi-asserted-by":"publisher","unstructured":"Emagneneh T, Mulugeta C, Ejigu B, Alamrew A, Hiwot AY, Feleke SF. Survival status of women with cervical cancer in Sub-Saharan Africa: a systematic review and meta-analysis, 2024. Front Oncol. 2025;14:1491840. https:\/\/doi.org\/10.3389\/fonc.2024.1491840.","DOI":"10.3389\/fonc.2024.1491840"},{"issue":"1","key":"4611_CR14","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1186\/s12905-023-02785-3","volume":"23","author":"JL Lacika","year":"2023","unstructured":"Lacika JL, Wabinga H, Kagaayi J, Opito R, Orach CG, Mwaka AD. Diagnostic and pre-treatment intervals among patients with cervical cancer attending care at the Uganda Cancer Institute: a cross-sectional study. BMC Womens Health. 2023;23(1):633.","journal-title":"BMC Womens Health"},{"key":"4611_CR15","doi-asserted-by":"publisher","first-page":"101069","DOI":"10.1016\/j.gore.2022.101069","volume":"43","author":"YQ Turdo","year":"2022","unstructured":"Turdo YQ, Ruffieux Y, Boshomane TMG, Mouton H, Taghavi K, Haas AD, Egger M, Maartens G, Rohner E. Cancer treatment and survival among cervical cancer patients living with or without HIV in South Africa. Gynecologic Oncol Rep. 2022;43:101069.","journal-title":"Gynecologic Oncol Rep"},{"issue":"1","key":"4611_CR16","first-page":"1","volume":"14","author":"C Njovu","year":"2022","unstructured":"Njovu C, Simonds H. Retrospective study of the treatment outcomes of cervical cancer in young women treated at a single institution. South Afr J Gynaecol Oncol. 2022;14(1):1\u20136.","journal-title":"South Afr J Gynaecol Oncol"},{"key":"4611_CR17","doi-asserted-by":"publisher","unstructured":"Dhokotera T, Asangbeh S, Bohlius J, Singh E, Egger M, Rohner E, Ncayiyana J, Clifford GM, Olago V, Sengayi-Muchengeti M. Cervical cancer in women living in South Africa: a record linkage study of the National Health Laboratory Service and the National Cancer Registry. ecancermedicalscience. 2022;16:1348. https:\/\/doi.org\/10.3332\/ecancer.2022.1348.","DOI":"10.3332\/ecancer.2022.1348"},{"issue":"1","key":"4611_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/ijgo.12749","volume":"145","author":"N Bhatla","year":"2019","unstructured":"Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet. 2019;145(1):129\u201335.","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"4611_CR19","doi-asserted-by":"publisher","first-page":"660","DOI":"10.6004\/jnccn.2020.0027","volume":"18","author":"NR Abu-Rustum","year":"2020","unstructured":"Abu-Rustum NR, Yashar CM, Bean S, Bradley K, Campos SM, Chon HS, Chu C, Cohn D, Crispens MA, Damast S. NCCN guidelines insights: cervical cancer, version 1.2020: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2020;18(6):660\u20136.","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"4611_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","volume":"17","author":"W-J Koh","year":"2019","unstructured":"Koh W-J, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, Chon HS, Chu C, Clark R, Cohn D. Cervical cancer, version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(1):64\u201384.","journal-title":"J Natl Compr Canc Netw"},{"key":"4611_CR21","doi-asserted-by":"publisher","first-page":"101094","DOI":"10.1016\/j.gore.2022.101094","volume":"44","author":"S Grover","year":"2022","unstructured":"Grover S, George J, Tuli S, Lichter K, Bhatia R, Monare B, Chinniah G, Bazzett-Matabele L, Bvochora-Nsingo M, Chiyapo S, et al. Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020. Gynecologic Oncol Rep. 2022;44:101094.","journal-title":"Gynecologic Oncol Rep"},{"issue":"4","key":"4611_CR22","doi-asserted-by":"publisher","first-page":"e0267571","DOI":"10.1371\/journal.pone.0267571","volume":"17","author":"T Tekalign","year":"2022","unstructured":"Tekalign T, Teshome M. Prevalence and determinants of late-stage presentation among cervical cancer patients, a systematic review and meta-analysis. PLoS ONE. 2022;17(4):e0267571.","journal-title":"PLoS ONE"},{"issue":"1","key":"4611_CR23","first-page":"1","volume":"4","author":"AJ Hunter","year":"2020","unstructured":"Hunter AJ, Hendrikse AS. Estimation of the eefcts of radiotherapy treatment delays on tumour responses: a review. SA J Oncol. 2020;4(1):1\u20139.","journal-title":"SA J Oncol"},{"key":"4611_CR24","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2147\/IJWH.S298204","volume":"13","author":"MN Nassali","year":"2021","unstructured":"Nassali MN, Melese T, Modimowame J, Moreri-Ntshabele B. Timelines to Cervical Cancer Diagnosis and Treatment at a Tertiary Hospital in Botswana. Int J Womens Health. 2021;13:385\u201393.","journal-title":"Int J Womens Health"},{"key":"4611_CR25","doi-asserted-by":"publisher","first-page":"102450","DOI":"10.1016\/j.canep.2023.102450","volume":"86","author":"IF da Silva","year":"2023","unstructured":"da Silva IF, da Silva IF, Saraceni V, Koifman RJ. Delays in treatment initiation and conclusion in women with stage IA to IIIB cervical cancer: A survival study in a hospital-based cohort from a developing country. Cancer Epidemiol. 2023;86:102450.","journal-title":"Cancer Epidemiol"},{"key":"4611_CR26","first-page":"1","volume":"5","author":"I Ferreira da Silva","year":"2019","unstructured":"Ferreira da Silva I, Ferreira da Silva I, Koifman RJ. Cervical cancer treatment delays and associated factors in a cohort of women from a developing country. J global Oncol. 2019;5:1\u201311.","journal-title":"J global Oncol"},{"key":"4611_CR27","doi-asserted-by":"publisher","first-page":"100697","DOI":"10.1016\/j.gore.2021.100697","volume":"35","author":"JAH Vargas","year":"2021","unstructured":"Vargas JAH, Barbosa PXR, Valbuena-Garcia AM, Acu\u00f1a L, Gonz\u00e1lez-Diaz JA. Factors associated with delays in time to treatment initiation in Colombian women with cervical cancer: A cross-sectional analysis. Gynecologic Oncol Rep. 2021;35:100697.","journal-title":"Gynecologic Oncol Rep"},{"issue":"10","key":"4611_CR28","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.6004\/jnccn.2019.7305","volume":"17","author":"GL Smith","year":"2019","unstructured":"Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J Natl Compr Canc Netw. 2019;17(10):1184\u201392.","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"4611_CR29","doi-asserted-by":"publisher","first-page":"e100871","DOI":"10.1136\/gpsych-2022-100871","volume":"35","author":"Y Wang","year":"2022","unstructured":"Wang Y, Feng W. Cancer-related psychosocial challenges. Gen psychiatry. 2022;35(5):e100871.","journal-title":"Gen psychiatry"},{"issue":"4","key":"4611_CR30","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","volume":"22","author":"R P\u00f6tter","year":"2021","unstructured":"P\u00f6tter R, Tanderup K, Schmid MP, J\u00fcrgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, et al. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol. 2021;22(4):538\u201347.","journal-title":"Lancet Oncol"},{"issue":"3","key":"4611_CR31","first-page":"322","volume":"5","author":"J Wu","year":"2025","unstructured":"Wu J, Jin Q, Zhang Y, Ji Y, Li J, Liu X, Duan H, Feng Z, Liu Y, Zhang Y. Global burden of cervical cancer: current estimates, temporal trend and future projections based on the GLOBOCAN 2022. J Natl Cancer Cent. 2025;5(3):322\u20139.","journal-title":"J Natl Cancer Cent"},{"issue":"10462","key":"4611_CR32","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1016\/S0140-6736(24)01438-7","volume":"404","author":"M McCormack","year":"2024","unstructured":"McCormack M, Eminowicz G, Gallardo D, Diez P, Farrelly L, Kent C, Hudson E, Panades M, Mathew T, Anand A, et al. Induction chemotherapy followed by standard chemoradiotherapy versus standard chemoradiotherapy alone in patients with locally advanced cervical cancer (GCIG INTERLACE): an international, multicentre, randomised phase 3 trial. Lancet. 2024;404(10462):1525\u201335.","journal-title":"Lancet"},{"issue":"10434","key":"4611_CR33","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","volume":"403","author":"D Lorusso","year":"2024","unstructured":"Lorusso D, Xiang Y, Hasegawa K, Scambia G, Leiva M, Ramos-Elias P, Acevedo A, Sukhin V, Cloven N, Pereira de Santana Gomes AJ, et al. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial. Lancet. 2024;403(10434):1341\u201350.","journal-title":"Lancet"},{"issue":"1","key":"4611_CR34","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1038\/s41598-024-85074-9","volume":"15","author":"X Liu","year":"2025","unstructured":"Liu X, Tian W, Dai A, Li H, Zhu M, Zeng M, Feng R, Zhang Z, Jiang X, Wen Y. A comparative analysis of toxicity and treatment outcomes of adaptive radiotherapy and intensity-modulated radiotherapy in cervical cancer. Sci Rep. 2025;15(1):1609.","journal-title":"Sci Rep"},{"key":"4611_CR35","doi-asserted-by":"publisher","first-page":"1552346","DOI":"10.3389\/fonc.2025.1552346","volume":"15","author":"A Mallum","year":"2025","unstructured":"Mallum A, Tendwa MB, Saidu R, Swanson W, Phan P, Li H, Ngoma T, Avery S, Huq MS, Akudugu JM. A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study. Front Oncol. 2025;15:1552346.","journal-title":"Front Oncol"},{"key":"4611_CR36","first-page":"186","volume":"5","author":"A Kavuma","year":"2021","unstructured":"Kavuma A, Luutu I, Kibudde S, Bangidde C. A retrospective review of conventional versus hypo-fractionated pelvic radiotherapy for locally advanced cervical cancer, in limited-resource countries: The Uganda experience. SA J Oncol. 2021;5:186.","journal-title":"SA J Oncol"},{"issue":"2","key":"4611_CR37","doi-asserted-by":"publisher","first-page":"e695","DOI":"10.1016\/j.ijrobp.2024.07.1529","volume":"120","author":"S Kibudde","year":"2024","unstructured":"Kibudde S, Fahhoum M, Ponce SB, Nankabirwa V, Nakalembe M, Kavuma A, Byakika P, Phipps W, Orem J, Beyer K. Hypofractionated radiotherapy in treatment of cervical cancer: A systematic review. Int J Radiat Oncol Biol Phys. 2024;120(2):e695\u20136.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4611_CR38","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","volume":"4","author":"S Shrivastava","year":"2018","unstructured":"Shrivastava S, Mahantshetty U, Engineer R, Chopra S, Hawaldar R, Hande V, Kerkar RA, Maheshwari A, Shylasree T, Ghosh J. Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial. JAMA Oncol. 2018;4(4):506\u201313.","journal-title":"JAMA Oncol"},{"issue":"2","key":"4611_CR39","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ygyno.2020.11.029","volume":"160","author":"AMD Fachini","year":"2021","unstructured":"Fachini AMD, Zuliani AC, Sarian LO, Teixeira JC, Esteves SCB, da Costa Machado H, Zeferino LC. Long-term outcomes of concomitant cisplatin plus radiotherapy versus radiotherapy alone in patients with stage IIIB squamous cervical cancer: A randomized controlled trial. Gynecol Oncol. 2021;160(2):379\u201383.","journal-title":"Gynecol Oncol"},{"key":"4611_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.radonc.2022.02.038","volume":"170","author":"V Hande","year":"2022","unstructured":"Hande V, Chopra S, Kalra B, Abdel-Wahab M, Kannan S, Tanderup K, Grover S, Zubizarreta E, Rubio JAP. Point-A vs. volume-based brachytherapy for the treatment of cervix cancer: A meta-analysis. Radiother Oncol. 2022;170:70\u20138.","journal-title":"Radiother Oncol"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-026-04611-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04611-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-026-04611-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:08:17Z","timestamp":1787785697000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12905-026-04611-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4611"],"URL":"https:\/\/doi.org\/10.1186\/s12905-026-04611-y","relation":{},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"20 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of the Witwatersrand Human Research Ethics Committee (HREC) Medical, Johannesburg, South Africa, approved the study (approval number M240862). The requirement for informed consent was waived by the HREC due to the study\u2019s retrospective design. The study was conducted in compliance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"429"}}